Eduardo González Pérez-Yarza
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Interests
Eduardo González Pérez-Yarza has a total of 397 co-authors. Here are the top co-authors by number of shared publications:
- Antonio Moreno-Galdó
Department of Pediatrics Universitat Autònoma de Barcelona Barcelona Spain
10 shared publications Olaia Sardón
Division of Pediatric Respiratory Medicine, Hospital Universitario Donostia San Sebastián, Spain
8 shared publicationsM. Montes
Hospital Universitario Donostia-Instituto Biodonostia
7 shared publications- Emilio Pérez-Trallero
Microbiology Department, Hospital Universitario Donostia-Instituto Biodonostia, San Sebastián, Spain
6 shared publications - Olaia Sardón-Prado
Division of Pediatric Respiratory Medicine, Hospital Universitario Donostia, 20014 San Sebastián, Spain
6 shared publications D. Vicente
Servicio de Microbiología, Hospital Donostia
5 shared publications
Latest Publications
- 9 October 2019
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 31 (2) , 124-132
Recurrent wheezing during the first 3 years of life in a birth cohort of moderate‐to‐late preterm infants
Background: Data addressing short‐ and long‐term respiratory morbidity in moderate‐late preterm infants are limited. We aim to determine the incidence of recurrent wheezing and associated risk and protective factors in these infants during the first 3 years of life.Methods: Prospective, multicenter birth cohort study of infants born at 32+0 to 35+0 weeks’ gestation and followed for 3 years to assess the incidence of physician‐diagnosed recurrent wheezing. Allergen sensitization and pulmonary function were also studied. We used multivariate mixed‐effects models to identify risk factors associated with recurrent wheezing.Results: A total of 977 preterm infants were enrolled. Rates of recurrent wheezing during year (Y)1 and Y2 were similar (19%) but decreased to 13.3% in Y3. Related hospitalizations significantly declined from 6.3% in Y1 to 0.75% in Y3. Independent risk factors for recurrent wheezing during Y2 and Y3 included the following: day care attendance, acetaminophen use during pregnancy, and need for mechanical ventilation. Atopic dermatitis on Y2 and male sex on Y3 were also independently associated with recurrent wheezing. Palivizumab prophylaxis for RSV during the first year of life decreased the risk or recurrent wheezing on Y3. While there were no differences in rates of allergen sensitization, pulmonary function tests (FEV0.5) were significantly lower in children who developed recurrent wheezing.Conclusions: In moderate‐to‐late premature infants, respiratory symptoms were associated with lung morbidity persisted during the first 3 years of life and were associated with abnormal pulmonary function tests. Only anti‐RSV prophylaxis exerted a protective effect in the development of recurrent wheezing.
- 9 October 2019
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 31 (2) , 124-132
Recurrent wheezing during the first 3 years of life in a birth cohort of moderate‐to‐late preterm infants
Background: Data addressing short‐ and long‐term respiratory morbidity in moderate‐late preterm infants are limited. We aim to determine the incidence of recurrent wheezing and associated risk and protective factors in these infants during the first 3 years of life.Methods: Prospective, multicenter birth cohort study of infants born at 32+0 to 35+0 weeks’ gestation and followed for 3 years to assess the incidence of physician‐diagnosed recurrent wheezing. Allergen sensitization and pulmonary function were also studied. We used multivariate mixed‐effects models to identify risk factors associated with recurrent wheezing.Results: A total of 977 preterm infants were enrolled. Rates of recurrent wheezing during year (Y)1 and Y2 were similar (19%) but decreased to 13.3% in Y3. Related hospitalizations significantly declined from 6.3% in Y1 to 0.75% in Y3. Independent risk factors for recurrent wheezing during Y2 and Y3 included the following: day care attendance, acetaminophen use during pregnancy, and need for mechanical ventilation. Atopic dermatitis on Y2 and male sex on Y3 were also independently associated with recurrent wheezing. Palivizumab prophylaxis for RSV during the first year of life decreased the risk or recurrent wheezing on Y3. While there were no differences in rates of allergen sensitization, pulmonary function tests (FEV0.5) were significantly lower in children who developed recurrent wheezing.Conclusions: In moderate‐to‐late premature infants, respiratory symptoms were associated with lung morbidity persisted during the first 3 years of life and were associated with abnormal pulmonary function tests. Only anti‐RSV prophylaxis exerted a protective effect in the development of recurrent wheezing.
- 1 April 2019
- Published by Elsevier in Archivos de Bronconeumología
- Vol. 55 (4) , 208-213
Disfunción de la pequeña vía aérea en niños con asma controlada
- 1 April 2019
- Published by Elsevier in Archivos de Bronconeumología
- Vol. 55 (4) , 208-213
Disfunción de la pequeña vía aérea en niños con asma controlada
- 25 March 2019
- Published by Wiley in Pediatric Pulmonology
- Vol. 54 (6) , 837-846
Isolated pulmonary interstitial glycogenosis associated with alveolar growth abnormalities: A long‐term follow‐up study
Introduction: Pulmonary interstitial glycogenosis (PIG) is a rare infant interstitial lung disease characterized by an increase in the number of interstitial mesenchymal cells, presenting as enhanced cytoplasmic glycogen, and is considered to represent the expression of an underlying lung development disorder.Methods: This study describes the clinical, radiological, and functional characteristics and long‐term outcomes (median 12 years) of nine infants diagnosed with isolated PIG associated with alveolar simplification in the absence of other diseases.Results: All patients presented with tachypnea. Additionally, seven patients had breathing difficulties and hypoxemia. Abnormalities in chest‐computerized tomography (CT) with a pattern of ground‐glass opacity, septal thickening, and air trapping were observed in all individuals, with images suggesting abnormal alveolar growth (parenchymal bands and architectural distortion). All lung biopsies showed alveolar simplification associated with an increased number of interstitial cells, which appeared as accumulated cytoplasmic glycogen. In the follow‐up, all patients were asymptomatic. The respiratory function test was normal in only two patients. Five children showed an obstructive pattern, and two children showed a restrictive pattern. Chest‐CT, performed after an average of 6.5 years since the initial investigation, revealed a partial improvement of the ground‐glass opacity pattern; however, relevant alterations persisted.Conclusion: Although the patients with PIG in the absence of other associated pathologies had a good clinical outcome, significant radiographic alterations and sequelae in lung function were still observed after a median follow‐up of 12 years, suggesting that PIG is a marker of some other persistent abnormalities in lung growth, which have effects beyond the symptomatic period.
- 25 March 2019
- Published by Wiley in Pediatric Pulmonology
- Vol. 54 (6) , 837-846
Isolated pulmonary interstitial glycogenosis associated with alveolar growth abnormalities: A long‐term follow‐up study
Introduction: Pulmonary interstitial glycogenosis (PIG) is a rare infant interstitial lung disease characterized by an increase in the number of interstitial mesenchymal cells, presenting as enhanced cytoplasmic glycogen, and is considered to represent the expression of an underlying lung development disorder.Methods: This study describes the clinical, radiological, and functional characteristics and long‐term outcomes (median 12 years) of nine infants diagnosed with isolated PIG associated with alveolar simplification in the absence of other diseases.Results: All patients presented with tachypnea. Additionally, seven patients had breathing difficulties and hypoxemia. Abnormalities in chest‐computerized tomography (CT) with a pattern of ground‐glass opacity, septal thickening, and air trapping were observed in all individuals, with images suggesting abnormal alveolar growth (parenchymal bands and architectural distortion). All lung biopsies showed alveolar simplification associated with an increased number of interstitial cells, which appeared as accumulated cytoplasmic glycogen. In the follow‐up, all patients were asymptomatic. The respiratory function test was normal in only two patients. Five children showed an obstructive pattern, and two children showed a restrictive pattern. Chest‐CT, performed after an average of 6.5 years since the initial investigation, revealed a partial improvement of the ground‐glass opacity pattern; however, relevant alterations persisted.Conclusion: Although the patients with PIG in the absence of other associated pathologies had a good clinical outcome, significant radiographic alterations and sequelae in lung function were still observed after a median follow‐up of 12 years, suggesting that PIG is a marker of some other persistent abnormalities in lung growth, which have effects beyond the symptomatic period.
- 11 March 2019
- Published by Elsevier in Archivos de Bronconeumología
- Vol. 55 (4) , 208-213
Small Airway Dysfunction in Children With Controlled Asthma
- 11 March 2019
- Published by Elsevier in Archivos de Bronconeumología
- Vol. 55 (4) , 208-213
Small Airway Dysfunction in Children With Controlled Asthma
- Open Access
- 1 February 2019
- Published by Elsevier in Anales de Pediatría
- Vol. 90 (2) , 109-117
Heterogeneidad de criterios en el diagnóstico de bronquiolitis aguda en España
- 1 February 2019
- Published by Elsevier in Anales de Pediatría
- Vol. 90 (2) , 109-117
Open AccessHeterogeneidad de criterios en el diagnóstico de bronquiolitis aguda en España
- Open Access
- 1 February 2019
- Published by Elsevier in Anales de Pediatría
- Vol. 90 (2) , 86-93
Hospitalizaciones infantiles asociadas a infección por virus de la gripe en 6 ciudades de España (2014-2016)
- 1 February 2019
- Published by Elsevier in Anales de Pediatría
- Vol. 90 (2) , 86-93
Open AccessHospitalizaciones infantiles asociadas a infección por virus de la gripe en 6 ciudades de España (2014-2016)
- Open Access
- 1 December 2018
- Published by Elsevier in Anales de Pediatría
- Vol. 89 (6) , 323-324
Celebrando los 50 años de Anales de Pediatría: manteniendo la tradición mientras fomentamos el cambio
- 1 December 2018
- Published by Elsevier in Anales de Pediatría
- Vol. 89 (6) , 323-324
Open AccessCelebrando los 50 años de Anales de Pediatría: manteniendo la tradición mientras fomentamos el cambio
- 1 July 2017
- Published by Elsevier in Expert Systems with Applications
- Vol. 78, 301-318
Improvement of newborn screening using a fuzzy inference system
- 1 July 2017
- Published by Elsevier in Expert Systems with Applications
- Vol. 78, 301-318
Improvement of newborn screening using a fuzzy inference system
- 1 August 2015
- Published by Elsevier in Anales de Pediatría
- Vol. 83 (2) , 94-103
Validación de la versión en español de la prueba de control del asma infantil (ACT) para su uso en España
- 1 August 2015
- Published by Elsevier in Anales de Pediatría
- Vol. 83 (2) , 94-103
Validación de la versión en español de la prueba de control del asma infantil (ACT) para su uso en España
- 1 June 2015
- Published by Elsevier in Archivos de Bronconeumología
- Vol. 51 (6) , 279-284
Patrones inflamatorios en niños asmáticos basados en la determinación de óxido nítrico alveolar
- 1 June 2015
- Published by Elsevier in Archivos de Bronconeumología
- Vol. 51 (6) , 279-284
Patrones inflamatorios en niños asmáticos basados en la determinación de óxido nítrico alveolar